Reports - Press Releases

Date	Title	Company
18-Feb-2026	FDA Grants PMA Approval to LimiFlex(TM) Dynamic Sagittal Tether	ACCESS Newswire
18-Feb-2026	Jaguar Health Announces a Special One-time Stock Dividend	ACCESS Newswire
18-Feb-2026	Tenon(R) Medical Strengthens Intellectual Property Portfolio with Strategic Patent Expansion	ACCESS Newswire
18-Feb-2026	Wellgistics Health Targets Expansion into $6.3 Billion Mental Health Software Market with Strategic Investment into Stealth Mental Health AI Startup	ACCESS Newswire
18-Feb-2026	Moderna Announces the U.S. Food and Drug Administration will Initiate the Review of Its Investigational Seasonal Influenza Vaccine Submission	ACCESS Newswire
18-Feb-2026	AQP ONE Launches JBA AICare(TM), Introducing a Physiological Intelligence System into the $100+ Billion Global Wearable Market	ACCESS Newswire
18-Feb-2026	Senzime Secures Credit Line Facility of 50 MSEK	ACCESS Newswire
18-Feb-2026	Senzime Q4 2025: Accelerated Growth and Continued Clear Path to Profitability	ACCESS Newswire
18-Feb-2026	Vicore Pharma to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference	ACCESS Newswire
18-Feb-2026	IRLAB: Invitation to the Year-End Report 2025 Presentation and Webcast	ACCESS Newswire
17-Feb-2026	MEDHOST Announces Strategic Partnership with RevSpring to Enhance Patient Engagement and Financial Experience Solutions	ACCESS Newswire
17-Feb-2026	Cercare Medical Releases Version 18 of Neurosuite: Advancing Stroke and Oncology Workflows	ACCESS Newswire
17-Feb-2026	The Language Group Announces Secure and Compliant On-Demand Healthcare Translation Platform Fetch is Now Patent-Protected	ACCESS Newswire
17-Feb-2026	Alpha Genesis Successfully Completes USDA Triennial Re-Licensing Inspection as Company Accelerates National Expansion	ACCESS Newswire
17-Feb-2026	The Naderi Center Highlights Simple Recovery and Long-Term Results of Earlobe Repair Surgery	ACCESS Newswire
17-Feb-2026	Aspire Biopharma Files Provisional Patent Application for a Fast-Acting Sublingual Powder Formulation of Meclizine (Generic Dramamine(R))	ACCESS Newswire
17-Feb-2026	Regentis Expands its European Clinical Site Network to Support its Commercial and Clinical Programs	ACCESS Newswire
17-Feb-2026	IGC Pharma Secures North American Composition Protection for IGC-AD1 as Phase 2 CALMA Enrollment Advances	ACCESS Newswire
17-Feb-2026	African Leaders Call for Sustainable Malaria Financing as Progress Stalls and Funding Crisis Deepens	ACCESS Newswire
17-Feb-2026	CNS Pharmaceuticals Appoints Multiple Key Executives to Drive Company's Recently Initiated Strategic Transformation	ACCESS Newswire